Intelligent Bio Solutions Inc. has successfully completed an exempt offering of securities, as indicated in a new Form D notice filed with the SEC. The offering, which closed on March 12, 2024, raised a total of $10,100,683 USD. The company, incorporated in Delaware and operating in the healthcare sector, specifically within the 'Other Health Care' category, has not disclosed its revenue range or aggregate net asset value. The securities offered included equity and options, warrants, or other rights to acquire another security. A minimum investment of $10,000 USD was accepted from outside investors, with a total of 8 investors participating in the offering. Sales commissions totaled $910,455 USD, paid to Ladenburg Thalmann & Co. Inc., which also received common stock warrants and reimbursement expenses. No proceeds from the offering are to be used for payments to executive officers, directors, or promoters. Intelligent Bio Solutions' principal place of business is located in New York, New York, with key executives including CEO Harry Simeonidis and CFO Spiro Sakiris.

Intelligent Bio Solutions Inc. has successfully completed an exempt offering of securities, as indicated in a new Form D notice filed with the SEC. The offering, which closed on March 12, 2024, raised a total of $10,100,683 USD. The company, incorporated in Delaware and operating in the healthcare sector, specifically within the 'Other Health Care' category, has not disclosed its revenue range or aggregate net asset value. The securities offered included equity and options, warrants, or other rights to acquire another security. A minimum investment of $10,000 USD was accepted from outside investors, with a total of 8 investors participating in the offering. Sales commissions totaled $910,455 USD, paid to Ladenburg Thalmann & Co. Inc., which also received common stock warrants and reimbursement expenses. No proceeds from the offering are to be used for payments to executive officers, directors, or promoters. Intelligent Bio Solutions' principal place of business is located in New York, New York, with key executives including CEO Harry Simeonidis and CFO Spiro Sakiris.